Cargando…
PL1 Peptide Engages Acidic Surfaces on Tumor-Associated Fibronectin and Tenascin Isoforms to Trigger Cellular Uptake
Tumor extracellular matrix (ECM) is a high-capacity target for the precision delivery of affinity ligand-guided drugs and imaging agents. Recently, we developed a PL1 peptide (sequence: PPRRGLIKLKTS) for systemic targeting of malignant ECM. Here, we map the dynamics of PL1 binding to its receptors F...
Autores principales: | Lingasamy, Prakash, Põšnograjeva, Kristina, Kopanchuk, Sergei, Tobi, Allan, Rinken, Ago, General, Ignacio J., Asciutto, Eliana K., Teesalu, Tambet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707168/ https://www.ncbi.nlm.nih.gov/pubmed/34959279 http://dx.doi.org/10.3390/pharmaceutics13121998 |
Ejemplares similares
-
Tumor-penetrating peptide for systemic targeting of Tenascin-C
por: Lingasamy, Prakash, et al.
Publicado: (2020) -
Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis
por: Simón-Gracia, Lorena, et al.
Publicado: (2021) -
Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide
por: Scodeller, Pablo, et al.
Publicado: (2017) -
Biarsenical ligands bind to endogenous G-protein α-subunits and enable allosteric sensing of nucleotide binding
por: Tõntson, Lauri, et al.
Publicado: (2013) -
Novel peptides for kinetic studies of ligand binding to melanocortin-4 receptors using fluorescence anisotropy
por: Link, Reet, et al.
Publicado: (2015)